Search Results

There are 35242 results for: content related to: Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin

  1. You have free access to this content
    Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients

    American Journal of Transplantation

    Volume 8, Issue 7, July 2008, Pages: 1384–1392, B. L. Kasiske, A. de Mattos, S. M. Flechner, L. Gallon, H.-U. Meier-Kriesche, M. R. Weir and A. Wilkinson

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1600-6143.2008.02272.x

  2. You have free access to this content
    Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials

    Transplant International

    Volume 24, Issue 12, December 2011, Pages: 1216–1230, Liset H. M. Pengel, Liang Q. Liu and Peter J. Morris

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1432-2277.2011.01357.x

  3. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells

    The Prostate

    Volume 75, Issue 7, May 15, 2015, Pages: 693–705, Kiren Yacqub-Usman, Mark R. Pickard and Gwyn T. Williams

    Version of Record online : 3 FEB 2015, DOI: 10.1002/pros.22952

  4. You have full text access to this Open Access content
    Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer

    Cancer Science

    Volume 100, Issue 12, December 2009, Pages: 2402–2410, Taro Matsuzaki, Masakazu Yashiro, Ryoji Kaizaki, Koichi Yasuda, Yosuke Doi, Tetsuji Sawada, Masaichi Ohira and Kosei Hirakawa

    Version of Record online : 18 AUG 2009, DOI: 10.1111/j.1349-7006.2009.01315.x

  5. You have free access to this content
    Immunosuppressive minimization with mTOR inhibitors and belatacept

    Transplant International

    Volume 28, Issue 8, August 2015, Pages: 921–927, Fritz Diekmann

    Version of Record online : 8 JUN 2015, DOI: 10.1111/tri.12603

  6. mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy

    Journal of Cellular Biochemistry

    Volume 114, Issue 6, June 2013, Pages: 1248–1256, Eun Ju Kim, Jae-Hoon Jeong, Sangwoo Bae, Seongman Kang, Cheol Hyeon Kim and Young-Bin Lim

    Version of Record online : 16 APR 2013, DOI: 10.1002/jcb.24465

  7. You have free access to this content
    Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 376–382, Bradley J. Atkinson, Diana H. Cauley, Chaan Ng, Randall E. Millikan, Lianchun Xiao, Paul Corn, Eric Jonasch and Nizar M. Tannir

    Version of Record online : 2 DEC 2013, DOI: 10.1111/bju.12420

  8. You have free access to this content
    Poster Abstracts

    American Journal of Transplantation

    Volume 17, Issue S3, April 2017, Pages: 411–815,

    Version of Record online : 19 APR 2017, DOI: 10.1111/ajt.14306

  9. Dose-level response rates of mTOR inhibition in tuberous sclerosis complex related subependymal giant cell astrocytoma

    Pediatric Blood & Cancer

    Volume 62, Issue 10, October 2015, Pages: 1754–1760, Danielle R. Weidman, Jason D. Pole, Eric Bouffet, Michael D. Taylor and Ute Bartels

    Version of Record online : 30 APR 2015, DOI: 10.1002/pbc.25573

  10. You have free access to this content
    Early use of mammalian target of rapamycin inhibitors is an independent risk factor for incisional hernia development after liver transplantation

    Liver Transplantation

    Volume 18, Issue 2, February 2012, Pages: 188–194, Roberto Montalti, Antonio Mimmo, Gianluca Rompianesi, Valentina Serra, Nicola Cautero, Roberto Ballarin, Nicola De Ruvo, Robert Cunningham Gerring, Giorgio Enrico Gerunda and Fabrizio Di Benedetto

    Version of Record online : 25 JAN 2012, DOI: 10.1002/lt.22445

  11. You have free access to this content
    mTOR inhibition: the learning curve in kidney transplantation

    Transplant International

    Volume 23, Issue 5, May 2010, Pages: 447–460, Matthew R. Weir, Fritz Diekmann, Stuart M. Flechner, Yvon Lebranchu, Didier A. Mandelbrot, Rainer Oberbauer and Barry D. Kahan

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1432-2277.2010.01051.x

  12. Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation

    The Journal of Clinical Pharmacology

    Volume 55, Issue 4, April 2015, Pages: 368–376, Michael J.G. Somers and Elahna Paul

    Version of Record online : 30 DEC 2014, DOI: 10.1002/jcph.428

  13. You have free access to this content
    Poster Abstracts

    American Journal of Transplantation

    Volume 11, Issue s2, April 2011, Pages: 213–527,

    Version of Record online : 4 APR 2011, DOI: 10.1111/j.1600-6143.2011.03534.x

    Corrected by:

    Erratum

    Vol. 11, Issue 8, 1760, Version of Record online: 28 JUL 2011

  14. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 12, Issue 6, June 2014, Pages: 480–488, Mareike Alter, Imke Satzger, Harald Schrem, Alexander Kaltenborn, Alexander Kapp and Ralf Gutzmer

    Version of Record online : 12 MAY 2014, DOI: 10.1111/ddg.12355

  15. You have full text access to this OnlineOpen article
    New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1486–1497, Mark Agulnik

    Version of Record online : 11 AUG 2011, DOI: 10.1002/cncr.26361

  16. You have free access to this content
    Targeting mTOR in renal cell carcinoma

    Cancer

    Volume 115, Issue S10, 15 May 2009, Pages: 2313–2320, Gary R. Hudes

    Version of Record online : 28 APR 2009, DOI: 10.1002/cncr.24239

  17. You have free access to this content
    Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates

    International Journal of Cancer

    Volume 132, Issue 7, 1 April 2013, Pages: 1711–1717, Mark A. Dickson, Gary K. Schwartz, Cristina R. Antonescu, David J. Kwiatkowski and Izabela A. Malinowska

    Version of Record online : 21 SEP 2012, DOI: 10.1002/ijc.27800

  18. You have free access to this content
    mTORC1- and mTORC2-interacting proteins keep their multifunctional partners focused

    IUBMB Life

    Volume 63, Issue 10, October 2011, Pages: 896–914, Ismael Bracho-Valdés, Paola Moreno-Alvarez, Israel Valencia-Martínez, Evelyn Robles-Molina, Lydia Chávez-Vargas and José Vázquez-Prado

    Version of Record online : 9 SEP 2011, DOI: 10.1002/iub.558

  19. You have free access to this content
    Posters

    Transplant International

    Volume 28, Issue S4, November 2015, Pages: 277–846,

    Version of Record online : 17 NOV 2015, DOI: 10.1111/tri.12702

  20. Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue 4, April 2016, Pages: 586–594, K. Sadowski, K. Kotulska, R. A. Schwartz and S. Jóźwiak

    Version of Record online : 25 SEP 2015, DOI: 10.1111/jdv.13356